New research aims to revolutionise meningitis control through advancing access to whole genome sequencing
Meningitis remains a significant global health challenge, claiming the lives of 1 in 10 people annually,
with children under five at greatest risk. Despite its devastating toll, the understanding and control of
meningitis is hindered by limited access to genome sequencing technology, particularly in low- and
middle-income countries, where the case numbers are highest.
.